Sanofi gets USFDA nod for Sarclisa (isatuximab-irfc) for refractory multiple myeloma Medical Dialogues Bureau4 March 2020 6:41 AM GMTSarclisa offers an intravenous (IV) administration and is dosed at 10 mg/kg, in combination with pom-dex, every week for four weeks and then every two...
Sanofi revival depends on outsider with nose for big drugs: Report Medical Dialogues Bureau3 Sep 2019 3:28 AM GMTDefining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson Farhat Nasim9 Jun 2019 3:55 AM GMTMarie-France Tschudin succeeds Paul Hudson who will be leaving Novartis to take the CEO position of a multinational pharmaceuticals company.Basel:...